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1. Introduction 
Cholera toxin exerts its effects on target cells by 
irreversibly activating the enzyme adenylate cyclase 
[ 1,2]. This toxin consists of two non-identical sub- 
units which are held together by non-covalent bonds. 
The A subunit consists of two non-identical peptide 
chains, Ar and Aa, of which Ar is the active peptide 
responsible for catalysing the NAD-dependent ribo- 
sylation of the guanine nucleotide regulatory unit of 
adenylate cyclase [3]. Associated with the two A pep- 
tides are 5 identical B subunits which each can bind 
toa G ml ganglioside. These glycolipids act as a cell 
surface receptor for the toxin molecule. 
In isolated membranes either cholera toxin itself 
or the isolated A subunit can activate adenylate 
cyclase directly [4,5]. However in intact cells there is 
a characteristic lag period before the onset of activa- 
tion of adenylate cyclase [ 1,2]. The duration of this 
lag period in intact hepatocytes is dependent upon 
cholera toxin concentration and upon the fluidity of 
the cell plasma membrane [6]. The lag time has also 
been shown to be related to the cell surface redistri- 
bution of fluorescent-labelled cholera toxin [7,8]. 
These observations led to the suggestion [6] that the 
lateral redistribution of bound toxin may be of 
importance to the process that allows the A subunit 
to gain access to the cytosol surface of the plasma 
membrane where it can act on the guanine nucleotide 
regulatory unit of adenylate cyclase. 
Receptor-mediated endocytosis has been shown to 
be an important mechanism by which cells rapidly 
bind and internalise specific extracellular ligands 
[9-121. A number of compounds interfere with 
aspects of this process [ 1 I], some of which are the 
lysomotropic agents, which specifically elevate the 
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pH in lysosomes [ 131. This study investigates the 
action of a number of such compounds on the chol- 
era toxin-mediated activation of adenylate cyclase in 
intact hepatocytes. 
2. Materials and methods 
Adenylate cyclase was assayed by a modification 
[ 151 of the procedure in [ 141. 
Isolated hepatocytes were prepared from 24 h 
starved, 250-300 g male Sprague-Dawley rats [16] 
and incubated in the medium of [ 171. Cells (3-5 mg 
dry wt/ml) were pre-incubated for 20 min with lactate 
(10 mM) and in some instances with the test ligands 
prior to the addition of cholera toxin (10 E.cg/ml). 
Incubations, gassing, sampling and the treatment of 
samples were as in [6]. 
Cholera toxin, lactate, chloroquine, dansyl cadav- 
erine and methylamine were from Sigma. Enzymes 
and other biochemicals were from Boehringer. All 
other chemicals were of AR grade from BDH. 
3. Results and discussion 
When isolated hepatocytes are exposed to cholera 
toxin (10 pg/ml) there is a lag period of -12 mm 
before activation of adenylate cyclase begins (fig.1). 
The extent of this lag period is believed to be related 
to the process by which the A subunit of cholera 
toxin at the extracellular surface gains access to 
adenylate cyclase at the intracellular surface of the 
plasma membrane [ 1,2,18,19]. It has been suggested 
[ 181 that the binding of the B subunit to the mem- 
brane causes a conformational change in the toxin 
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Fig.1. The action of lysomotropic agents on the activation of 
adenylate cyclase in intact hepatocytes. Cells were pre- 
treated as described in the text: control (0); 10 mM NH,CI 
(m); 0.4 mM chloroquine (0); 10 mM methylamine (A) and 
0.1 mM dansyl cadaverine (0) before exposure to cholera 
toxin (10 gg/ml). Samples were taken at various time inter- 
vals for assessment of adenylate cyclase activity after break- 
ing the cells. 
such that the A subunit is able to penetrate through 
the bilayer and interact with the guanine nucleotide 
regulatory subunit of adenylate cyclase at the cytosol 
side of the membrane. However, besides the obvious 
thermodynamic difficulties this poses, if the lag 
period did reflect such an event it is difficult to see 
why it should be affected by toxin concentration [6] 
and also why it is apparently unaffected by cova- 
lently cross-linking the A and B subunits together 
[20]. Furthermore, the A chain of cholera toxin does 
not appear to be inserted into the bilayer when the 
toxin binds to ganglioside-containing lipid vesicles 
[21]. Thus the direct penetration of the A subunit 
through the plasma membrane appears to be unlikely,. 
Fluorescent-labelled cholera toxin has been dem- 
onstrated to bind to cell surface gangliosides, where it 
undergoes lateral redistribution into patches and in 
some instances can form caps at one pole of the cell 
[7,8,19]. This demonstrates that toxin bound to the 
membrane is mobile in the plane of the membrane. 
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Many multivalent ligands that aggregate cell-surface 
receptors are recruited to coated pits whereupon they 
are rapidly internalised in endocytotic (coated) vesi- 
cles (see [ lo,1 1,221). Coated vesicles have been 
shown to be involved in plasma membrane retrieval, 
membrane recycling and exocytosis [ 10,23,24] as 
well as endocytosis, thus providing a shuttle system 
between the plasma and intracellular membranes. 
Pre-treatment of cells with NH4C1, aliphatic 
amines, chloroquine and dansyl cadaverine has been 
shown to inhibit the infectivity of various viruses 
which enter the cell through coated vesicles [25-271; 
to inhibit the receptor-mediated endocytosis of 
a,-macroglobulin [ 111; to inhibit the entry of the 
toxic lectin, modeccin into target cells [ 281; to 
inhibit the receptor-mediated uptake of lysosomal 
enzymes into fibroblasts [29]; to block the action of 
pseudomonas exotoxin on mouse LM-fibroblasts 
[30] and to block the action of diptheria toxin 
[31,32]. All of these basic compounds are rapidly 
taken up by cells and concentrated within the lyso- 
somes where they raise the pH of this compartment 
[ 13,251 and inhibit the action of lysosomal proteases 
[ 13,33,34]. 
If hepatocytes, prior to their exposure to cholera 
toxin, are incubated with either of ammonium chlo- 
ride (10 mM), dansyl cadaverine (100 MM), methyl- 
amine (10 mM) or chloroquine (400 PM) then marked 
effects are seen on both the lag of onset of adenylate 
cyclase activation and the rate at which activation 
ensues (fig.1). All of these agents act to markedly 
extend the length of the lag period and, with the 
exception of dansyl cadaverine, they decrease the rate 
at which activation of adenylate cyclase occurs. Chol- 
era toxin acts on adenylate cyclase by virtue of the 
ability of the A subunit to cause the ribosylation of 
the guanine nucleotide regulatory protein [3] in a 
process that requires NAD+ and GTP. It is unlikely 
that these agents exert their effects through decreas- 
ing the NAD+ or GTP concentrations as hepatocytes 
treated with a number of these agents have been 
shown to be metabolically competent although their 
rates of protein degradation are significantly decreased 
[35,36]. Furthermore, we have shown [6] that in 
hepatocytes the lag period and rate of adenylate 
cyclase activation by cholera toxin are relatively 
insensitive to rather larger changes in both the cyto- 
plasmic NAD’INADH ratio and the cytoplasmic ATP 
concentration. 
We suggest hat the active, A, subunit of cholera 
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toxin becomes available at the cytoplasmic surface of 
the plasma membrane by virtue of the to&n being endo- 
cytosed, processed in the lysosomes and re-cycled 
back to the plasma membrane. We envisage that lyso- 
somal processing would lead to the insertion of the 
A subunit through to the cytosol surface of the 
endocytosed vesicle membrane. Membranes contain- 
ing the A subunit would be recycled back to the 
plasma membrane where the toxin could interact 
with and activate all adenylate cyclase units through 
the ability of these components to undergo free 
lateral diffusion in the bilayer [37,38]. Support for 
our contention comes from observations that cholera 
toxin has been shown to undergo endocytosis by 
neuroblastoma cells [39]. Indeed, after endocytosis, 
cholera toxin can be seen associated with the golgi or 
GERL complex which have been shown to be involved 
in the re-cycling of intemalised undegraded plasma 
membrane [39]. The compounds tested may then 
exert their action on this process at two points. They 
could either inhibit endocytosis or prevent the inser- 
tion of the A subunit into the membrane during pro- 
cessing and re-cycling. There are indeed precedents 
for both of these suggested modes of action. 
(i) 
(ii) 
Dansyl cadaverine and methylamine have been 
demonstrated to block the receptor mediated 
endocytosis of +macroglobulin by a mechanism 
which is thought to involve inhibition of trans- 
glutaminase [ 1 I]. 
Whilst the various lysomotropic agents we have 
tested did not inhibit the receptor-mediated endo- 
cytosis of intact Semliki Forest Virus into animal 
cells, they did prevent the spike proteins in the 
viral envelope from integrating into the mem- 
brane of the endocytosed vesicle in order to form 
a channel for the nucleocapsid to pass across this 
membrane and enter the cytoplasm [25]. 
Lysosomal processing is believed to play a key role 
in the mechanism of entry and action of toxins into 
cells, as the action of many plant, bacterial and ani- 
mal toxins, including diptheria toxin which is strut? 
turally relaied to cholera toxin, is inhibited by lyso- 
motropic agents [28,40]. The mechanism by which 
these agents achieve their effects is far from clear. 
However as cross-linked toxin can activate adenylate 
cyclase [20] it is possible that proteolysis of the 
endocytosed toxin may be important in allowing the 
release of the A-subunit and its subsequent penetra- 
tion across the membrane. Recycling of undegraded 
plasma membrane from lysosomes has been demon- 
strated to be a rapid process in a number of cell types 
[41,42] and indeed recycling of plasma membrane in 
hepatocytes occurs at a rapid rate [42]. This, coupled 
with the ability of relatively small numbers of cholera 
toxin molecules to activate the entire pool of adenyl- 
ate cyclase [6] by collisions during free lateral diffu- 
sion, could account for the duration of the well- 
defined lag period before activation is seen in intact 
cells. Thus cholera toxin may enter and act on cells 
by a similar mechanism to that used by many other 
toxins. 
Acknowledgements 
This work was supported by grants from the MRC 
to M. D. H. and K. R. F. E. We thank Mr Sushi1 
Rawal for excellent technical assistance. 
References 
[l] Van Heyningen, S. (1977) Biol. Rev. 52,509-549. 
[2] Vaughn, M. and Moss, J. (1978) J. Supramol. Struct. 8, 
473-488. 
[ 31 Cassel, D. and Pfeuffer, T. (1978) Proc. Natl. Acad. Sci. 
USA 75,2669-2673. 
[4] Martin, B. R., Houslay, M. D. and Kennedy, E. L. 
(1977) Biochem. J 161,639-642. 
[S] Van Heyningen, S. and King, C. A. (1975) Biochem. J
146,269-271. 
[6] Houslay, M. D. and Elliott, K. R. F. (1979) FEBS Lett. 
[71 
I81 
PI 
1101 
[Ill 
[I21 
[I31 
(14 
[I5 
104,359-363. 
Craig, S. W. and Cuatrecasas, P. (1975) Proc. Natl. 
Acad. Sci. USA 72,3844-3848. 
Revesz, T. and Greaves, M. (1975) Nature 257, 
103-106. 
Anderson, R. G. W., Goldstein, J. L. and Brown, M. S. 
(1977) Nature 270,695-699. 
Goldstein, J. L., Anderson, R. G. W. and Brown, M. S. 
(1979) Nature 279,679-685. 
Davies, P. J. A., Davies, D. R., Levitzki, A., Maxfield, 
F. R., Milhaud, P., Will&ham, M. C. and Pastan, I.
(1980) Nature 283, 162-167. 
Schlessinger, J., Schechter, Y., Cuatrecasas, P.
Willingham, M. C. and Pastan, I. (1978) Proc. Natl. 
Acad. Sci. USA 75,5353-5357. 
DeDuve, C., DeBarsy, T., Poole, B., Trouet, A., 
TuIkens, P. and Van Hoof, F. (1974) Biochem. Pharma- 
col. 23,2495-2531. 
Houslay, M. D., Metcalfe, J. C., Warren, G. B., Hesketh, 
T. R. and Smith, G. A. (1976) Biochim. Biophys. Acta 
436,489-494. 
Houslay, M. D. and Palmer, R. W. (1978) Biochem. J
174,909-919. 
291 
Volume 128. number 2 FEBS LETTERS June 1981 
[16] Elliott, K. R. F., Ash, R., Pogson, C. I., Smith, S. A. 
and Crisp, D. M. (1976) in: Use of isolated liver cells 
and kidney tubules in metabolic studies (Tager , J . M. et 
al. eds) pp. 139-143, Elsevier/North-Holland, 
Amsterdam, New York. 
[17] Smith, S. A., Elliott, K. R. F. and Pogson, C. I. (1978) 
Biochem. J. 176,817-825. 
1181 Gill, D. M. (1976) Biochemistry 15, 1242-1248. 
[19] Sahyoun, N. and Cuatrecasas, P. (1975) Proc. Nan. 
Acad. Sci. USA 72,3438-3442. 
120) Van Heyningen, S. (1977) Biochem. J. 168,457-463. 
[21] Tomasi, M., Ausiello, C., Battistini, A. and D’Agnolo, 
G. (1979) FEBS Lett. 106,309-313. 
[22] Houslay, M. D. (1981) Biosci. Rep. 1, 19-34. 
[23] Heuser, J. E. (1978) in: Transport of Macromolecules in 
Cellular Systems (Silverstein, S. C. ed) pp. 445-464, 
Konferenzer, Berlin/Dahlem. 
[24] Franke, W. W., Lueder, M. R., Kartenbeck, J., Zerban, 
H. and Keenan, T. W. (1976) J. Cell Biol. 69, 173-195. 
[25] Helen&, A., Kartenbeck, J., Simons, K. and Fries, E. 
(1980) J. Cell Biol. 84,404-420. 
[26] Fletcher, R. D., Hirschfeld, J. E. and Forbes, M. (1965) 
Nature 207,664-665. 
[27] Jensen, S. C. and Liu, 0. C. (1963) Proc. Sot. Exp. 
Biol. Med. 112,456-459. 
[28] Sandvig, K., Olsnes, S. and Pihl, A. (1979) Biochem. 
Biophys. Res. Commun. 90,648-655. 
[ 291 Sando G. N., Titus-Dillon, P., Hall, C. W. and Neufeld, 
E. F. (1979) Exptl. Cell. Res. 119,359-364. 
[30] Fitzgerland, D., Morris, R. E. and Saelinger, C. B. 
(1980) Cell 21,867-873. 
[ 311 Olsnes, S., Haylett, T. and Refsnes, K. (1978) J. Biol. 
Chem. 253,5069-5073. 
[ 321 Bonventre, P. F., Saelinger, C. B., Ivens, B., Voscinski, 
C. and Amorini, M. (1975) Infect. Immunol. 11, 
675-684. 
[ 331 King, C. A., Hermaez-Davis, C. and Cuatrecasas, P. 
(1980) Proc. Natl. Acad. Sci. USA 77, 3283-3287. 
(341 Okhuma, S. and Poole, B. (1978) Proc. Natl. Acad. Sci. 
USA 75, 3327-3331. 
[35] Seglan, P. O., Grinde, B. and Solheim, A. F. (1979) Eur. 
J. Biochem. 95,215-255. 
[36] Crabb, D. W., Jersild, R. A., McCune, S. A., 
Swartzentruber, M. S. and Harris, R. A. (1980) Arch. 
Biochem. Biophys. 203,49-57. 
[37] Houslay, M. D., Ellory, J. C., Smith, G. A., Hesketh, 
T. R., Stein, J. M., Warren, G. B. and Metcalfe, J. C. 
(1977) Biochim. Biophys. Acta 467, 208-219. 
[38] Martin, B. R., Stein, J. M., Kennedy, E. L., Doberska, 
C. A. and Metcalfe, J. C. (1979) Biochem. J. 184, 
253-260. 
[39] Joseph, K. C., Stieber, A., Gonatos, N. K. (1979) J. Cell 
Biol. 81,543-554. 
[40] Hughes, R. C. (1979) Nature 281,526-527. 
[41] Doyle, D. and Baumann, H. (1979) Life Sci. 24, 
951-966. 
[42) Thilo, L. and Vogel, G. (1980) Proc. Natl. Acad. Sci. 
USA 77,1015-1019. 
[43] Stanley, K. K., Edwards, M. R. and Luzio, J. P. (1980) 
Biochem. J. xx, xxxx. 
292 
